Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6928541 | 0.96 | GFER (0.47) | GFERROCK2RAB9AGAASMN1; SMN2 | |
| SCHEMBL6925007 | 0.95 | RAB9A (0.48) | GFERROCK2RAB9AGAASMN1; SMN2 | |
| SCHEMBL5981597 | 0.86 | S1PR1 (0.51) | GFERRAB9AGAASMN1; SMN2NPC1 | |
| SCHEMBL11349673 | 0.83 | RAB9A (0.54) | GFERRAB9AGAASMN1; SMN2NPC1 | |
| SCHEMBL16302352 | 0.79 | RAB9A (0.58) | GFERRAB9AGAASMN1; SMN2NPC1 | |
| SCHEMBL1397633 | 0.79 | IDO1 (0.50) | GAAALDH1A1PTGS1PTGS2MEN1 | |
| SCHEMBL21727343 | 0.79 | PTGS1 (0.51) | GFERRAB9AGAASMN1; SMN2NPC1 | |
| SCHEMBL11346034 | 0.78 | RAB9A (0.59) | GFERRAB9AGAASMN1; SMN2NPC1 | |
| SCHEMBL20220042 | 0.76 | GFER (0.42) | GFERRAB9AGAANPC1PTGS1 | |
| SCHEMBL13801923 | 0.75 | HDAC8 (0.57) | GFERRAB9AGAASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12133906-B2 | Delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2024-11-05 | — | — | US | disclosed |
| US-20220409497-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2022-12-29 | — | — | US | disclosed |
| EP-3733827-A1 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2020-11-04 | — | — | EP | disclosed |
| EP-2563508-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-07-10 | — | — | EP | disclosed |
| EP-1642563-B1 | Method of rapid hair dyeing | NOXELL CORP (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20190142714-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-05-16 | — | — | US | disclosed |
| EP-1484048-B1 | Hair colouring compositions | NOXELL CORP (US) | 2019-01-02 | — | — | EP | disclosed |
| US-20180360706-A1 | Delivery Particles | PROCTER & GAMBLE (US) | 2018-12-20 | — | — | US | disclosed |
| EP-2308564-B1 | Thickened hair colourant and bleaching compositions | NOXELL CORP (US) | 2018-12-19 | — | — | EP | disclosed |
| US-9993793-B2 | Delivery particles | THE PROCTER & GAMBLE COMPANY (US) | 2018-06-12 | — | — | US | disclosed |
| US-20050188476-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | PROCTER & GAMBLE COMPANY, THE | 2005-09-01 | — | — | US | disclosed |
| WO-2005077324-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2005-08-25 | — | — | WO | disclosed |
| WO-2005074875-A2 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2005-08-18 | — | — | WO | disclosed |
| WO-2004108102-A1 | HAIR COLOURING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2004-12-16 | — | — | WO | disclosed |
| EP-1484048-A1 | Hair colouring compositions | The Procter & Gamble Company (US) | 2004-12-08 | — | — | EP | disclosed |
| US-20040237218-A1 | Hair colouring compositions | WELLA OPERATIONS US, LLC | 2004-12-02 | — | — | US | disclosed |
| CN-1477948-A | Novel couplers for oxidative hair dyeing | P&G克莱罗尔公司 | 2004-02-25 | — | — | CN | disclosed |
| EP-1363587-A1 | NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING | P&G-Clairol, Inc. (US) | 2003-11-26 | — | — | EP | disclosed |
| US-6409773-B1 | AMINOPHENOL COUPLERS | CLAIROL INCORPORATED | 2002-06-25 | — | — | US | disclosed |
| WO-2002047635-A1 | NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING | P&G-CLAIROL, INC. (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409497-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | GFER 2767/4885ROCK2 3780/4885RAB9A 2130/4885 |
| US-20180360706-A1 | Delivery Particles | LIPA, CHMP4B, ABCB4 | GFER 2518/4885ROCK2 3735/4885RAB9A 2217/4885 |
| US-12133906-B2 | Delivery particle | LIPA, CHMP4B, SLC46A1 | GFER 2767/4885ROCK2 3780/4885RAB9A 2130/4885 |
| US-20190142714-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | GFER 2767/4885ROCK2 3780/4885RAB9A 2130/4885 |
| US-20040237218-A1 | Hair colouring compositions | COXFA4L2, CYBA, MT-CO3 | GFER 274/4885ROCK2 4710/4885RAB9A 4508/4885 |
| US-20050188476-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | KRT18, JUP, CKMT1A; CKMT1B | GFER 543/4885ROCK2 3472/4885RAB9A 4007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.